Advertisement

Adnextumoren mit apokriner Differenzierung

  • S. Kaddu
  • H.-P. Soyer
  • H. Kerl

Zusammenfassung

Kutane Adnextumoren mit duktaler Differenzierung unterteilt man üblicherweise in Tumoren mit apokriner und ekkriner Differenzierung. Die morphologische Unterscheidung ist nicht immer eindeutig, weil die Drüsenausführungsgänge apokriner und ekkriner Adnextumoren morphologisch häufig nicht unterscheibar sind. Das klassische morphologische Merkmal für Adnextumoren mit apokriner Differenzierung, die so genannte „Dekapitationsekretion“, kann man gelegentlich auch bei Adnextumoren mit ekkriner Differenzierung beobachten. Deshalb gibt es noch immer Debatten über die Histogenese einiger dieser kutanen Adnextumoren mit duktaler Differenzierung. Der Großteil der apokrinen Adnextumoren ist gutartig, und nur selten wurden bösartige Varianten beschrieben. Maligne apokrine Adnextumoren weisen ein breites morphologisches Spektrum auf, wodurch manchmal eine eindeutige histologische Klassifikation erschwert wird (Tabelle 31.1).

Synonym

Polythelie Ceruminom Hidradenom der Vulva Adenoma hidradenoides chondroides Syringom papilläres tubuläres Adenom tubulopa-pilläres Hidradenom malignes Syringom Schweißdrüsenkarzinom mit syringoiden Merkmalen sklerosierendes Schweißdrüsenkarzinom 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ansai S, Koseki S, Hozumi Y, Kondo S (1995) An immunohistochemical study of lysozyme, CD-15 (Leu Mi), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation. Am J Dermatopathol 17: 249–255Google Scholar
  2. Gianotti R, Coggi A, Alessi E (1998) Cutaneous apocrine mixed tumor: Derived from the apocrine duct of the folliculosebaceous-apocrine unit? Am J Dermatopathol 20: 323–325PubMedCrossRefGoogle Scholar
  3. Mazoujian G, Pinkus GS, Haagensen DE Jr (1984) Extra-mammary Paget’s disease–evidence for an apocrine origin. An immunoperoxidase study of gross cystic disease fluid protein-15, carcinoembryonic antigen, and keratin proteins. Am J Surg Pathol 8: 43–50PubMedCrossRefGoogle Scholar
  4. Ohnishi T, Watanabe S (1997) Histogenesis of mixed tumor of the skin, apocrine type: Immunohisto chemical study of keratin expression. Am J Dermatopathol 19: 456–461Google Scholar
  5. Requena L, Kiryu H, Ackerman AB (1998) Neoplasms with apocrine differentiation. Lippincott-Raven, PhiladelphiaGoogle Scholar
  6. Ando K, Hashikawa Y, Nakashima M, Nakayama A, Ohashi M (1991) Pure apocrine nevus: a study of light microscopic and immunohistochemical features of a rare tumor. Am J Dermatopathol 13: 71–76PubMedCrossRefGoogle Scholar
  7. Herrmann JJ, Eramo LR (1995) Congenital apocrine hamartoma: An unusual clinical variant of organoid nevus with apocrine differentiation. Pediatr Dermatol 12: 248–251Google Scholar
  8. Neill JS, Park HK (1993) Apocrine nevus: Light microscopic, immunohistochemical and ultrastructural studies of a case. J Cutan Pathol 20: 79–83Google Scholar
  9. Rabens SF, Naness JI, Gottlieb BF (1976) Apocrine gland organic hamartoma (apocrine nevus). Arch Dermatol 112: 520–522PubMedCrossRefGoogle Scholar
  10. Vakilzadeh F, Happle R, Peters P, Macher E (1976) Fokale dermale Hypoplasie mit apokrinen Naevi und streifenförmiger Anomalie der Knochen. Arch Dermatol Res 256: 189–195PubMedCrossRefGoogle Scholar
  11. Müller-Hess S, Delacretaz J (1973) Trichoepitheliom mit Strukturen eines apocrinen Adenoms. Dermatologica 146: 170–176PubMedCrossRefGoogle Scholar
  12. Okun MR, Finn R, Blumental G (1980) Apocrine adenoma 31 versus apocrine carcinoma. Report of two cases. J Am Acad Dermatol 2: 322–326Google Scholar
  13. Warkel RL, Helwig EB (1978) Apocrine gland adenoma and adenocarcinoma of the axilla. Arch Dermatol 114: 198–203PubMedCrossRefGoogle Scholar
  14. Camisa C (1980) Accessory breast on the posterior thigh of a man. J Am Acad Dermatol 3: 467–469PubMedCrossRefGoogle Scholar
  15. Hrabovszky T, Schneider I, Zombai E (1995) Axilläre akzessorische Brustdrüse. Hautarzt 46: 576–578PubMedCrossRefGoogle Scholar
  16. Toumbis-loannou E, Cohen PR (1994) Familial polythelia. J Am Acad Dermatol 30: 667–668CrossRefGoogle Scholar
  17. Weinberg SK, Motulsky AG (1976) Aberrant axillary breast tissue: A report of a family with six affected women in two generations. Clin Genet 10: 325–328Google Scholar
  18. Lynde CW, McLean DI, Wood WS (1984) Tumors of cerumi-nous glands. J Am Acad Dermatol u: 841–847Google Scholar
  19. Michel RG, Woodard BH, Shelburne JD, Bossen EH (1978) Ceruminous gland adenocarcinoma: A light and electron microscopic study. Cancer 41: 545–553Google Scholar
  20. Neldner KH (1968) Ceruminoma. Arch Dermatol 98: 344–348CrossRefGoogle Scholar
  21. Wetli CV, Pardo V, Millard M, Gerston K (1972) Tumors of ceruminous glands. Cancer 29: 169–178CrossRefGoogle Scholar
  22. Brownstein MH, Phelps RG, Magnin PH (1985) Papillary adenoma of the nipple: Analysis of fifteen new cases. J Am Acad Dermatol 12: 707–715Google Scholar
  23. Hödl S, Kerl H, Kresbach H (1978) Krankheiten im Bereich der Mamille. Hautarzt 29: 548–549PubMedGoogle Scholar
  24. Marsch WC, Nürnberger F (1979) Das Mamillenadenom. Z Hautkr 54: 1067–1072PubMedGoogle Scholar
  25. Montemarano AD, Sau P, James WD (1995) Superficial papillary adenomatosis of the nipple: A case report and review of the literature. J Am Acad Dermatol 33: 871–875Google Scholar
  26. Smith NP, Wilson Jones E (1977) Erosive adenomatosis of the nipple. Clin Exp Dermatol 2: 79–84PubMedCrossRefGoogle Scholar
  27. Requena L, Sanchez Yus E, Santa Cruz DJ (1992) Apocrine type of cutaneous mixed tumor with follicular and sebaceous differentiation. Am J Dermatopathol 14: 186–194PubMedCrossRefGoogle Scholar
  28. Wilk M, Klesper D, Uerlich M, Biwer E, Wimheuer R (1994) Chondroides Syringom. Immunohistologische Hinweise für eine myoepitheliale Differenzierung. Hautarzt 45: 324–329Google Scholar
  29. Zumdick M, Milde P, Ruzicka T, Hölzle E (1995) Apokriner kutaner Mischtumor mit follikulärer Differenzierung. Hautarzt 46: 481–484PubMedCrossRefGoogle Scholar
  30. Karnbach C, Neuber K, Diaz-Cascajo C, Steinkraus V (1998) Syringocystadenoma papilliferum und Trichoblastom innerhalb eines Naevus sebaceus. Hautarzt 49: 654–656PubMedCrossRefGoogle Scholar
  31. Mammino JJ,Vidmar DA (1991) Syringocystadenoma papilliferum. Int J Dermatol 30: 763–766CrossRefGoogle Scholar
  32. Mensing H, Jaenner M (1981) Naevus sebaceus Jadassohn und Syringocystadenoma papilliferum. Epitheliale Hamartombildungen der Haut. Hautarzt 32: 130–135Google Scholar
  33. Pullmann H, Pfeiff B (1985) Syringocystadenoma papilliferum als Differentialdiagnose eines Unterlippenkarzinoms. Z Hautkr 60: 348–355PubMedGoogle Scholar
  34. Vanatta PR, Bangert JL, Freeman RG (1985) Syringocystadenoma papilliferum. A plasmacytotropic tumor. Am J Surg Pathol 9: 678–683Google Scholar
  35. Toribio J, Zulaica A, Peteiro C (1987) Tubular apocrine adenoma. J Cutan Pathol 14: 114–117PubMedCrossRefGoogle Scholar
  36. Ceballos PI, Penneys NS, Acosta R (1990) Aggressive digital papillary adenocarcinoma. J Am Acad Dermatol 23: 331–334PubMedCrossRefGoogle Scholar
  37. Duke WH, Sherrod TT, Lupton GP (2000) Aggressive digital papillary adenocarcinoma (aggressive digital papillary adenoma and adenocarcinoma revisited). Am J Surg Pathol 24: 775–784PubMedCrossRefGoogle Scholar
  38. Kao GF, Helwig EB, Graham JH (1987) Aggressive digital papillary adenoma and adenocarcinoma. A clinico-pathological study of 57 patients, with histo chemical, immunopathological, and ultrastructural observations. J Cutan Pathol 14: 129–146PubMedCrossRefGoogle Scholar
  39. Dhawan SS, Nanda VS, Grekin S, Rabinovitz HS (1990) Apocrine adenocarcinoma: Case report and review of the literature. J Dermatol Surg Oncol 16: 468–470Google Scholar
  40. Kuno Y, Numata T, Kanzaki T (1999) Adenocarcinoma with signet ring cells of the axilla showing apocrine features: A case report. Am J Dermatopathol 21: 37–41Google Scholar
  41. Nishikawa Y, Tokusashi Y, Saito Y, Ogawa K, Miyokawa N, Katagiri M (1994) A case of apocrine adenocarcinoma associated with hamartomatous apocrine gland hyperplasia of both axillae. Am J Surg Pathol 18: 832–836PubMedCrossRefGoogle Scholar
  42. Stout AP, Cooley SGE (1951) Carcinoma of sweat glands. Cancer 4: 521–536PubMedCrossRefGoogle Scholar
  43. Warkel RL, Helwig EB (1978) Apocrine gland adenoma and adenocarcinoma of the axilla. Arch Dermatol 114: 198–203PubMedCrossRefGoogle Scholar
  44. Armitage NC, Jass JR, Richman PI, Thomson JP, Phillips RK (1989) Paget’s disease of the anus: A clinicopathological study. Br J Surg 76: 60–63Google Scholar
  45. Goldblum JR, Hart WR (1998) Perianal Paget’s disease: A histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma. Am J Surg Pathol 22: 170–179PubMedCrossRefGoogle Scholar
  46. Lautier R, Achtelik WV, Wolff HH (1990) Immunhistochemische Untersuchungen beim mammären und extramammären Morbus Paget weisen auf eine apokrine Differenzierung. Z Hautkr 65: 571–574PubMedGoogle Scholar
  47. Neumann R (1986) Extramammärer Morbus Paget–assozi- iert mit einem Magenkarzinom. Hautarzt 37: 568–570PubMedGoogle Scholar
  48. Urabe A, Matsukuma A, Shimizu N, Nishimura M, Wada H, Hori Y (1990) Extramammary Paget’s disease: Comparative histopathologic studies of intraductal carcinoma of the breast and apocrine adenocarcinoma. J Cutan Pathol 17: 257–265Google Scholar
  49. Bates AW, Baithun SI (1998) Atypical mixed tumor of the skin: Histologic, immunohistochemical, and ultrastructural features in three cases and a review of the criteria for malignancy. Am J Dermatopathol zo: 35–40Google Scholar
  50. Ishimura E, Iwamoto H, Kobashi Y, Yamabe H, Ichijima K (1983) Malignant chondroid syringoma. Report of a case with widespread metastasis and review of pertinent literature. Cancer 52: 1966–1973Google Scholar
  51. Metzler G, Schaumburg-Lever G, Hornstein O, Rassner G (1996) Malignant chondroid syringoma: Immunohistopathology. Am J Dermatopathol 18: 83–89Google Scholar
  52. Trown K, Heenan PJ (1994) Malignant mixed tumor of the skin (malignant chondroid syringoma). Pathology 26: 237–243PubMedCrossRefGoogle Scholar
  53. Antley CA, Carney M, Smoller BR (1999) Microcystic adnexal carcinoma arising in the setting of previous radiation therapy. J Cutan Pathol 26: 48–50PubMedCrossRefGoogle Scholar
  54. Carroll P, Goldstein GD, Brown CW Jr (2000) Metastatic microcystic adnexal carcinoma in an immunocompromised patient. Dermatol Surg 26: 531–534PubMedCrossRefGoogle Scholar
  55. Friedman PM, Friedman RH, Jiang SB, Nouri K, Amonette R, Robins P (1999) Microcystic adnexal carcinoma: Collaborative series review and update. J Am Acad Dermatol 41: 225–231Google Scholar
  56. Goldstein DJ, Barr RJ, Santa Cruz DJ (1982) Microcystic adnexal carcinoma: A distinct clinicopathologic entity. Cancer 50: 566–572Google Scholar
  57. Rank C, Bastian BC, Pistner H, Bröcker EB, Hamm H (1996) Das mikrozystische Adnexkarzinom der Haut. Hautarzt 47: 284–288PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • S. Kaddu
  • H.-P. Soyer
  • H. Kerl

There are no affiliations available

Personalised recommendations